UNYQLA Trademark

Trademark Overview


On Thursday, November 19, 2015, a trademark application was filed for UNYQLA with the United States Patent and Trademark Office. The USPTO has given the UNYQLA trademark a serial number of 86825501. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 30, 2017. This trademark is owned by Glaxo Group Limited. The UNYQLA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
unyqla

General Information


Serial Number86825501
Word MarkUNYQLA
Filing DateThursday, November 19, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 30, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 3, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 24, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Monday, January 30, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 30, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 28, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 3, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 3, 2016PUBLISHED FOR OPPOSITION
Wednesday, April 13, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 29, 2016ELECTRONIC RECORD REVIEW COMPLETE
Friday, March 25, 2016ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, March 15, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 11, 2016ASSIGNED TO EXAMINER
Tuesday, November 24, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 23, 2015NEW APPLICATION ENTERED IN TRAM